article Open AccessTop 1% cited

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

Nephrology Dialysis Transplantation · 2014 · Vol. 29(11) · pp. 2075–2084

Iain C. Macdougall✉(King's College Hospital)A. Böck(Kantonsspital Aarau)Fernando CarreraKai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg)Sandrine Gaillard(University of Groningen)David Van WyckBernard Roubert(Vifor Pharma (Switzerland))Jessica Nolen(Vifor Pharma (Switzerland))Simon D. Roger(Gosford Hospital)on behalf of the FIND-CKD Study Investigators

View via DOI Full-text PDF

Abstract

NCT00994318.

Iron Metabolism and Disorders Erythropoietin and Anemia Treatment Hemoglobinopathies and Related DisordersMedicineKidney diseaseIron deficiencyGastroenterologyInternal medicineFerritinAnemiaAdverse effectDialysisClinical endpoint

MeSH terms

Administration, OralAgedDose-Response Relationship, DrugFemaleFerric CompoundsFerritinsFollow-Up StudiesRenal DialysisHemoglobinsHumansInjections, IntravenousIronMaleMaltoseProspective Studies

Funding

Amgen
Vifor Pharma
Cilag

Citations

323

FWCI

18.39

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

References

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Annals of Internal Medicine · 1999 · 15,085 citations

Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.